Showing results (41-50 of 841) with videos related to
Sort By:
Pageof 85
Journal of Clinical Psychopharmacology|February 16, 2022
Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine TreatmentHitoshi Sakurai, Bettina Hoeppner, Felipe Jain, et al.General Hospital Psychiatry|April 12, 2023
Ages at menarche and menopause, hormone therapy, and the risk of depressionHyewon Kim, Jin Hyung Jung, Kyungdo Han, et al.Depression and Anxiety|October 10, 2020
Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC studyManish Kumar Jha, Maurizio Fava, Abu Minhajuddin, et al.The Journal of Clinical Psychiatry|June 25, 2010
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressantsMarlene P Freeman, David Mischoulon, Enrico Tedeschini, et al.Psychological Medicine|March 8, 2022
High body weight variability is associated with increased risk of depression: a nationwide cohort study in South KoreaMi Jin Park, Juhwan Yoo, Kyungdo Han, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 4, 2009
Frontal EEG predictors of treatment outcome in major depressive disorderDan V Iosifescu, Scott Greenwald, Philip Devlin, et al.Journal of Affective Disorders|February 25, 2021
Increased risk of depression before and after unilateral or bilateral oophorectomy: A self-controlled case series study using a nationwide cohort in South KoreaHyewon Kim, Yuwon Kim, Maurizio Fava, et al.Journal of Affective Disorders|August 20, 2025
Impulsive loss decision-making associated with aberrant meso-/habenular- cortical functional networks in young adults with major depressive disorder with suicidal ideationJaejoong Kim, Hyewon Kim, Sunghwan Kim, et al.Human Psychopharmacology|June 20, 2006
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysisAmy H Farabaugh, Shamsah B Sonawalla, Maurizio Fava, et al.Psychiatry Research|August 30, 2008
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorderGeorge I Papakostas, Patrick McGrath, Jonathan Stewart, et al.Pageof 85